Neogenomics share#snapshot#suffix 1589606 / US64049M2098
16.36
USD
0.34
USD
2.10 %
09.10.2026
BTT
| prices + charts + realtime | news + analysis | fundamental | company | corresponding shares | action | |
|---|---|---|---|---|---|---|
| price + Chart | chart (large) | news + ad-hoc | balance sheet/p&l | fixed dates | certificates | portfolio#add_instrument_to#depot |
| times + sale | chart comparison | analysis | detailnavigation#shares#estimates | profile | portfolio#add_instrument_to#watchlist | |
| stock exchange | realtime push | stock price appreciation potential | dividend/annual shareholders' meeting | |||
| historic | analysis | |||||
prices + charts + realtime
news + analysis
fundamental
company
corresponding shares
Neogenomics Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2025 | Neogenomics IncShs | 0.00 | 0.00 | USD |
| 2024 | Neogenomics IncShs | 0.00 | 0.00 | USD |
| 2023 | Neogenomics IncShs | 0.00 | 0.00 | USD |
| 2022 | Neogenomics IncShs | 0.00 | 0.00 | USD |
| 2021 | Neogenomics IncShs | 0.00 | 0.00 | USD |
| 2020 | Neogenomics IncShs | 0.00 | 0.00 | USD |
| 2019 | Neogenomics IncShs | 0.00 | 0.00 | USD |
| 2018 | Neogenomics IncShs | 0.00 | 0.00 | USD |
| 2017 | Neogenomics IncShs | 0.00 | 0.00 | USD |
| 2016 | Neogenomics IncShs | 0.00 | 0.00 | USD |
share#balance#profitpershare- Neogenomics
| -0.8 25 | -0.6 24 | -0.7 23 | -1.2 22 | -0.1 21 | 0.0 20 | 0.1 19 |
share#balance#salespershare- Neogenomics
| 5.7 25 | 5.2 24 | 4.7 23 | 4.1 22 | 4.0 21 | 4.0 20 | 3.9 19 |
share#balance#p_e_ratio- Neogenomics
| 1443 20 | 378 19 |
Neogenomics IncShs: share#balance#headline#theshare (in USD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (berichtet) | -0.84 | -0.62 | -0.70 | -1.16 | -0.07 | 0.04 | 0.08 |
| Gewinn je Aktie (unverwässert) | -0.84 | -0.62 | -0.70 | -1.16 | -0.07 | 0.04 | 0.08 |
| Gewinn je Aktie (verwässert) | -0.84 | -0.62 | -0.70 | -1.16 | -0.07 | 0.04 | 0.08 |
| Dividende je Aktie | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Veränderung Dividende je Aktie in % | - | - | - | - | - | - | - |
| share#balance#cell#dividend_payment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Neogenomics IncShs: share#balance#business_ratio (in USD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| share#balance#cell#sales_share | 5.68 | 5.22 | 4.71 | 4.10 | 4.04 | 3.98 | 3.95 |
| KGV (Jahresendkurs, Gewinn unverwässert) | - | - | - | - | - | 1’443.43 | 378.40 |
| KGV (Jahresendkurs, Gewinn verwässert) | - | - | - | - | - | 1’443.43 | 378.40 |
| share#balance#cell#dividend_ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| share#balance#cell#equity_ratio | 61.52 | 55.09 | 56.00 | 57.36 | 59.27 | 66.38 | 71.52 |
| share#balance#cell#debt_ratio | 38.48 | 44.91 | 44.00 | 42.64 | 40.73 | 33.62 | 28.48 |
Neogenomics IncShs: share#balance#headline#income_statement (in Mio. USD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| share#balance#cell#sales | 727.33 | 660.57 | 591.64 | 509.73 | 484.33 | 444.45 | 408.83 |
| share#balance#cell#sales_change | 10.11 | 11.65 | 16.07 | 5.24 | 8.97 | 8.71 | 47.73 |
| share#balance#cell#sales_gross_profit | 282.54 | 256.65 | 209.47 | 173.25 | 179.57 | 165.48 | 176.01 |
| share#balance#cell#sales_gross_profit_change | 10.09 | 22.52 | 20.91 | -3.52 | 8.52 | -5.99 | 54.75 |
| share#balance#cell#operating_income | -66.08 | -71.70 | -96.65 | -150.63 | -95.21 | -12.39 | 16.20 |
| share#balance#cell#operating_income_change | 7.83 | 25.82 | 35.84 | -58.21 | -668.32 | - | 31.29 |
| share#balance#cell#income_before_tax | -110.27 | -80.68 | -97.10 | -159.34 | -15.08 | -14.06 | 3.65 |
| share#balance#cell#income_before_tax_change | -36.68 | 16.91 | 39.06 | -957.00 | -7.25 | - | -4.68 |
| share#balance#cell#income_after_tax | -108.03 | -78.73 | -87.97 | -144.25 | -8.35 | 4.17 | 8.01 |
| share#balance#cell#income_after_tax_change | -37.22 | 10.51 | 39.02 | -1’628.17 | - | -47.89 | 203.26 |
Neogenomics IncShs: share#balance#headline#balance (in Mio. USD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Fremdkapital | 523 | 736 | 740 | 742 | 762 | 352 | 202 |
| Langzeit Gesamtverbindlichk. je Aktie | 3.37 | 3.39 | 5.05 | 5.14 | 5.43 | 2.48 | 1.32 |
| share#balance#cell#total_equity | 837 | 902 | 942 | 998 | 1’108 | 694 | 507 |
| share#balance#cell#total_equity_change | -7.29 | -4.16 | -5.66 | -9.95 | 59.63 | 36.83 | 58.35 |
| share#balance#cell#total_liabilities_and_equity | 1’360 | 1’638 | 1’681 | 1’740 | 1’870 | 1’046 | 710 |
| share#balance#cell#total_liabilities_and_equity_change | -16.98 | -2.57 | -3.38 | -6.94 | 78.77 | 47.41 | 40.49 |
Neogenomics IncShs: share#balance#headline#other_data (in USD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (unverwässert) | -0.84 | -0.62 | -0.70 | -1.16 | -0.07 | 0.04 | 0.08 |
| Veränderung Gewinn je Aktie (unverwässert) in % | -35.67 | 11.31 | 39.65 | -1’568.53 | -281.25 | -51.82 | 12.10 |
| Gewinn je Aktie (verwässert) | -0.84 | -0.62 | -0.70 | -1.16 | -0.07 | 0.04 | 0.08 |
| Veränderung Gewinn je Aktie (verwässert) in % | -35.67 | 11.31 | 39.65 | -1’568.53 | -286.60 | -51.75 | 16.24 |
| share#balance#cell#employees | 2’500 | 2’200 | 2’100 | 2’100 | 2’000 | 1’700 | 1’700 |
| share#balance#cell#employees_change | 13.64 | 4.76 | 0.00 | 5.00 | 17.65 | 0.00 | 13.33 |
Neogenomics IncShs Termine
| Unternehmen | Event | Datum |
|---|---|---|
| Neogenomics IncShs | Quartalszahlen | 10.11.2026 |
| Neogenomics IncShs | Quartalszahlen | 23.02.2027 |
| Neogenomics IncShs | Quartalszahlen | 04.05.2027 |
| Neogenomics IncShs | Quartalszahlen | 03.08.2027 |
Neogenomics IncShs vergangene Termine
| Terminart | Info | Datum |
|---|---|---|
| Quartalszahlen | Q2 2026 Earnings Release | 28.07.2026 |
| Hauptversammlung | Annual General Meeting | 21.05.2026 |
| Quartalszahlen | Q1 2026 Earnings Release | 28.04.2026 |
| Quartalszahlen | Q4 2025 Earnings Release | 17.02.2026 |
| Quartalszahlen | Q3 2025 Earnings Release | 28.10.2025 |
| Quartalszahlen | Q2 2025 Earnings Release | 29.07.2025 |
| Hauptversammlung | Annual General Meeting | 22.05.2025 |
| Quartalszahlen | Q1 2025 Earnings Release | 29.04.2025 |
| Quartalszahlen | Q4 2024 Earnings Release | 18.02.2025 |
| Quartalszahlen | Q3 2024 Earnings Release | 05.11.2024 |
| Quartalszahlen | Q2 2024 Earnings Release | 29.07.2024 |
| Hauptversammlung | Annual General Meeting | 23.05.2024 |
| Quartalszahlen | Q1 2024 Earnings Release | 30.04.2024 |
| Quartalszahlen | Q4 2023 Earnings Release | 20.02.2024 |
| Quartalszahlen | Q3 2023 Earnings Release | 06.11.2023 |
| Quartalszahlen | Q2 2023 Earnings Release | 08.08.2023 |
| Hauptversammlung | Annual General Meeting | 25.05.2023 |
| Quartalszahlen | Q1 2023 Earnings Release | 08.05.2023 |
| Quartalszahlen | Q4 2022 Earnings Release | 23.02.2023 |
| Quartalszahlen | Q3 2022 Earnings Release | 08.11.2022 |
| Quartalszahlen | Q2 2022 Earnings Release | 09.08.2022 |
| Hauptversammlung | Annual General Meeting | 02.06.2022 |
| Quartalszahlen | Q1 2022 Earnings Release | 27.04.2022 |
| Quartalszahlen | Q4 2021 Earnings Release | 23.02.2022 |
share#companyprofile#balance#staff#headline
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| share#companyprofile#balance#staff#employees | 1’700 | 1’700 | 2’000 | 2’100 | 2’100 |
| share#companyprofile#balance#staff#salesperemployee | 0.24 | 0.26 | 0.24 | 0.24 | 0.28 |
Bilanz (in Mio. USD) - Aktiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| share#companyprofile#balance#staff#currentassets | 291 | 449 | 682 | 605 | 597 |
| share#companyprofile#balance#staff#fixedassets | 419 | 597 | 1’188 | 1’135 | 1’084 |
| share#companyprofile#balance#staff#totalassets | 710 | 1’046 | 1’870 | 1’740 | 1’681 |
Bilanz (in Mio. USD) - Passiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| share#companyprofile#balance#staff#totalborrowing | 202 | 352 | 762 | 742 | 740 |
| share#companyprofile#balance#staff#totalequity | 507 | 694 | 1’108 | 998 | 942 |
| share#companyprofile#balance#staff#totalliabilities | 710 | 1’046 | 1’870 | 1’740 | 1’681 |